Table 2 Demographic characteristics of the participants in the experimental and control groups classified by treatment being received
From: The feasibility of integrating a home telehealth model for older persons living with hemodialysis
Receiving treatment | Experimental group | Control group | χ2 | P |
|---|---|---|---|---|
(n = 24) | (n = 30) | |||
Kidney replacement therapy | Â | Â | 3.375 | 0.066 |
  Did not receive | (41.7) 10 | (66.7) 20 |  |  |
  Received | (58.3) 14 | (33.3) 10 |  |  |
Duration of receiving treatment | Â | Â | 26.375 | 0.000** |
  1 –5 years | (85.7) 12 | (70.0) 7 |  |  |
   > 5 years | (14.3) 2 | 3 (30.0) |  |  |
  Experienced kidney replacement therapy problems; had to return to hospital | (28.6) 4 | (40.0) 4 |  |  |
Illness with other diseases | 19 (79.2) | 27 (90.0) | 26.421 | 0.000** |
  Diabetes mellitus | (50.0) 12 | (50.0) 15 |  |  |
  Hypertension | (70.8)17 | (80.0) 24 |  |  |
  Heart disease | (37.5) 9 | (23.3) 7 |  |  |
  Lung disease | (4.2) 1 | (3.3) 1 |  |  |
  Gouty arthritis | (8.3) 2 | (20.0) 6 |  |  |